BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1186 related articles for article (PubMed ID: 25847151)

  • 1. Mitochondrial dynamics and inherited peripheral nerve diseases.
    Pareyson D; Saveri P; Sagnelli A; Piscosquito G
    Neurosci Lett; 2015 Jun; 596():66-77. PubMed ID: 25847151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of mitochondrial network dynamics in the pathogenesis of Charcot-Marie-Tooth disease.
    Palau F; Estela A; Pla-Martín D; Sánchez-Piris M
    Adv Exp Med Biol; 2009; 652():129-37. PubMed ID: 20225023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Review of the recent literature on hereditary neuropathies].
    Birouk N
    Rev Neurol (Paris); 2014 Dec; 170(12):846-9. PubMed ID: 25459128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
    Cartoni R; Martinou JC
    Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations.
    Cassereau J; Chevrollier A; Gueguen N; Desquiret V; Verny C; Nicolas G; Dubas F; Amati-Bonneau P; Reynier P; Bonneau D; Procaccio V
    Exp Neurol; 2011 Jan; 227(1):31-41. PubMed ID: 20849849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.
    Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C
    Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update.
    Tazir M; Hamadouche T; Nouioua S; Mathis S; Vallat JM
    J Neurol Sci; 2014 Dec; 347(1-2):14-22. PubMed ID: 25454638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.
    Baloh RH; Schmidt RE; Pestronk A; Milbrandt J
    J Neurosci; 2007 Jan; 27(2):422-30. PubMed ID: 17215403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease].
    Sołtysińska E; Kabzińska D; Kochański A
    Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults.
    Ouvrier R; Grew S
    Dev Med Child Neurol; 2010 Apr; 52(4):328-30. PubMed ID: 20163430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex.
    Misko A; Jiang S; Wegorzewska I; Milbrandt J; Baloh RH
    J Neurosci; 2010 Mar; 30(12):4232-40. PubMed ID: 20335458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features.
    Bombelli F; Stojkovic T; Dubourg O; Echaniz-Laguna A; Tardieu S; Larcher K; Amati-Bonneau P; Latour P; Vignal O; Cazeneuve C; Brice A; Leguern E
    JAMA Neurol; 2014 Aug; 71(8):1036-42. PubMed ID: 24957169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2.
    Züchner S; De Jonghe P; Jordanova A; Claeys KG; Guergueltcheva V; Cherninkova S; Hamilton SR; Van Stavern G; Krajewski KM; Stajich J; Tournev I; Verhoeven K; Langerhorst CT; de Visser M; Baas F; Bird T; Timmerman V; Shy M; Vance JM
    Ann Neurol; 2006 Feb; 59(2):276-81. PubMed ID: 16437557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of axonal dysfunction and traffic impairments in CMT.
    Gentil BJ; Cooper L
    Brain Res Bull; 2012 Aug; 88(5):444-53. PubMed ID: 22595495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ultrastructural lesions of axonal mitochondria in patients with childhood-onset Charcot-Marie-Tooth disease due to MFN2 mutations].
    Funalot B; Magdelaine C; Sturtz F; Ouvrier R; Vallat JM
    Bull Acad Natl Med; 2009 Jan; 193(1):151-60; discussion 160-1. PubMed ID: 19718987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar clinical, pathological, and genetic features in Chinese patients with autosomal recessive and dominant Charcot-Marie-Tooth disease type 2K.
    Fu J; Dai S; Lu Y; Wu R; Wang Z; Yuan Y; Lv H
    Neuromuscul Disord; 2017 Aug; 27(8):760-765. PubMed ID: 28495047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease.
    Montecchiani C; Pedace L; Lo Giudice T; Casella A; Mearini M; Gaudiello F; Pedroso JL; Terracciano C; Caltagirone C; Massa R; St George-Hyslop PH; Barsottini OG; Kawarai T; Orlacchio A
    Brain; 2016 Jan; 139(Pt 1):73-85. PubMed ID: 26556829
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 60.